Patent Law and the Emerging Science of Synthetic Biology: An Examination of Principle and Practice: Part 2

Research output: Contribution to journalArticle

Abstract

Scientists at the Venter Institute have filed several families of patent applications for tools and techniques in synthetic biology. These include a minimal bacterial genome, methods for creating synthetic genomes and cells, and methods of DNA assembly. This section examines the scope of the claimed inventions and how they have been treated by the United States patent and Trademark Office (USPTO). Analysis of patent examining practices is important because it reveals whether the validity criteria are applied such that high-quality patents are being granted. High-quality patents-which meet the statutory requirements for patentability, can help to drive innovation, while poor-quality patents can hinder it. Ensuring high-quality patents is important for promoting innovation in synthetic biology. This both courts and USPTO should stringently apply the patent-eligible subject matter tests and validity criteria.
LanguageEnglish
Pages105-116
Number of pages12
JournalBiotechnology Law Report
Volume36
Issue number3
DOIs
Publication statusPublished - 1 Jun 2017

Fingerprint

Synthetic Biology
Patents
Artificial Cells
Bacterial Genomes
innovation
genome
science
patent
Genome
DNA

Cite this

@article{ddae892fc6884f35be3914c6ccdeb881,
title = "Patent Law and the Emerging Science of Synthetic Biology: An Examination of Principle and Practice: Part 2",
abstract = "Scientists at the Venter Institute have filed several families of patent applications for tools and techniques in synthetic biology. These include a minimal bacterial genome, methods for creating synthetic genomes and cells, and methods of DNA assembly. This section examines the scope of the claimed inventions and how they have been treated by the United States patent and Trademark Office (USPTO). Analysis of patent examining practices is important because it reveals whether the validity criteria are applied such that high-quality patents are being granted. High-quality patents-which meet the statutory requirements for patentability, can help to drive innovation, while poor-quality patents can hinder it. Ensuring high-quality patents is important for promoting innovation in synthetic biology. This both courts and USPTO should stringently apply the patent-eligible subject matter tests and validity criteria.",
keywords = "synthetic biology, patent, gene patent, biotechnology, Myriad, Venter",
author = "Alison MCLENNAN",
year = "2017",
month = "6",
day = "1",
doi = "10.1089/blr.2017.29021.am",
language = "English",
volume = "36",
pages = "105--116",
journal = "Biotechnology Law Report",
issn = "0730-031X",
publisher = "Mary Ann Liebert Inc",
number = "3",

}

Patent Law and the Emerging Science of Synthetic Biology: An Examination of Principle and Practice : Part 2. / MCLENNAN, Alison.

In: Biotechnology Law Report, Vol. 36, No. 3, 01.06.2017, p. 105-116.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Patent Law and the Emerging Science of Synthetic Biology: An Examination of Principle and Practice

T2 - Biotechnology Law Report

AU - MCLENNAN, Alison

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Scientists at the Venter Institute have filed several families of patent applications for tools and techniques in synthetic biology. These include a minimal bacterial genome, methods for creating synthetic genomes and cells, and methods of DNA assembly. This section examines the scope of the claimed inventions and how they have been treated by the United States patent and Trademark Office (USPTO). Analysis of patent examining practices is important because it reveals whether the validity criteria are applied such that high-quality patents are being granted. High-quality patents-which meet the statutory requirements for patentability, can help to drive innovation, while poor-quality patents can hinder it. Ensuring high-quality patents is important for promoting innovation in synthetic biology. This both courts and USPTO should stringently apply the patent-eligible subject matter tests and validity criteria.

AB - Scientists at the Venter Institute have filed several families of patent applications for tools and techniques in synthetic biology. These include a minimal bacterial genome, methods for creating synthetic genomes and cells, and methods of DNA assembly. This section examines the scope of the claimed inventions and how they have been treated by the United States patent and Trademark Office (USPTO). Analysis of patent examining practices is important because it reveals whether the validity criteria are applied such that high-quality patents are being granted. High-quality patents-which meet the statutory requirements for patentability, can help to drive innovation, while poor-quality patents can hinder it. Ensuring high-quality patents is important for promoting innovation in synthetic biology. This both courts and USPTO should stringently apply the patent-eligible subject matter tests and validity criteria.

KW - synthetic biology

KW - patent

KW - gene patent

KW - biotechnology

KW - Myriad

KW - Venter

U2 - 10.1089/blr.2017.29021.am

DO - 10.1089/blr.2017.29021.am

M3 - Article

VL - 36

SP - 105

EP - 116

JO - Biotechnology Law Report

JF - Biotechnology Law Report

SN - 0730-031X

IS - 3

ER -